Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 10/20 | 0.50 |
| ▸ | MME | P08473 | 9/20 | 0.50 |
| ▸ | CASP1 | P29466 | 2/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.49 |
| ▸ | MMP8 | P22894 | 1/20 | 0.48 |
| ▸ | MMP14 | P50281 | 1/20 | 0.48 |
| ▸ | F2 | P00734 | 2/20 | 0.48 |
| ▸ | PLAU | P00749 | 2/20 | 0.48 |
| ▸ | PLAT | P00750 | 2/20 | 0.48 |
| ▸ | KLK8 | O60259 | 1/20 | 0.48 |
| ▸ | F10 | P00742 | 1/20 | 0.48 |
| ▸ | PLG | P00747 | 1/20 | 0.48 |
| ▸ | KLK1 | P06870 | 1/20 | 0.48 |
| ▸ | KLK2 | P20151 | 1/20 | 0.48 |
| ▸ | KLK4 | Q9Y5K2 | 1/20 | 0.48 |
| ▸ | KYNU | Q16719 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23881738 | 0.94 | CASP1 (0.51) | ECE1MMECASP1ACE2MMP8 | |
| SCHEMBL23881753 | 0.94 | ACE2 (0.47) | ECE1MMECASP1ACE2MMP8 | |
| SCHEMBL23881893 | 0.93 | ACE2 (0.48) | ECE1MMECASP1ACE2MMP8 | |
| SCHEMBL23881850 | 0.93 | ACE2 (0.50) | ECE1MMEACE2MMP8MMP14 | |
| SCHEMBL23881880 | 0.92 | ATM (0.52) | ECE1MMEACE2MMP8MMP14 | |
| SCHEMBL23881767 | 0.92 | ECE1 (0.59) | ECE1MMECASP1ACE2MMP8 | |
| SCHEMBL23881675 | 0.90 | CASP1 (0.56) | ECE1MMECASP1ACE2MMP8 | |
| SCHEMBL23881707 | 0.90 | MEN1 (0.46) | ECE1MMEACE2MMP8MMP14 | |
| SCHEMBL23881797 | 0.90 | MEN1 (0.46) | ECE1MMECASP1ACE2F2 | |
| SCHEMBL23881969 | 0.88 | ACE2 (0.55) | ECE1MMEACE2MMP8MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11192907-B2 | Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same | QUANTUM GENOMICS (FR) | 2021-12-07 | — | — | US | disclosed |
| US-20210309678-A1 | AMINOPEPTIDASE A INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | Institut National de la Santé et de la Recherche Médicale (FR) | 2021-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11192907-B2 | Aminopeptidase A inhibitors and pharmaceutical compositions comprising the same | ANPEP, DNPEP, ENPEP | ECE1 54/4885MME 15/4885CASP1 2019/4885 |
| US-20210309678-A1 | AMINOPEPTIDASE A INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | ANPEP, DNPEP, ENPEP | ECE1 54/4885MME 15/4885CASP1 2019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.